宫颈癌同步放化疗中盆腔骨髓脂肪含量变化与外周血细胞毒性相关性研究
该研究前瞻性收集54例宫颈癌同步放化疗患者数据,采用MRI IDEAL IQ序列在放疗前、放疗中点、放疗结束及6个月时量化盆腔骨髓质子密度脂肪分数(PDFF%)变化,并按5-10 Gy、10-15 Gy、15-20 Gy、20-30 Gy、30-40 Gy、40-50 Gy及>50 Gy剂量梯度分析。结果显示淋巴细胞(ALC)最低点出现在放疗中点(为放疗前的27.6%),白细胞(WBC)、中性粒细胞(ANC)和血小板(PLT)最低点出现在放疗结束时(分别为放疗前的52.4%、65.1%、69.3%);放疗中点及结束时PDFF%分别增加46.8%和58.5%。PDFF%与5-10 Gy剂量区ANC最低点呈显著正相关(r=0.62,P=0.006),与5-10 Gy剂量区ALC最低点亦存在相关性(r=0.554,P=0.017)。结论认为MRI IDEAL IQ成像可无创评估和追踪同步放化疗中盆腔骨髓脂肪含量变化,应更加关注宫颈癌同步放化疗中低剂量骨髓照射体积的限制。
要点
- 宫颈癌同步放化疗中,ALC最低点出现在放疗中点(为放疗前27.6%),WBC、ANC、PLT最低点出现在放疗结束时(分别为放疗前52.4%、65.1%、69.3%)。
- 放疗中点及结束时PDFF%分别较放疗前增加46.8%和58.5%;6个月时5-30 Gy剂量区PDFF%较放疗结束下降4.71%,但仍较放疗前增加55.95%。
- PDFF%与5-10 Gy剂量区ANC最低点呈显著正相关(r=0.62,P=0.006),与5-10 Gy剂量区ALC最低点亦存在相关性(r=0.554,P=0.017)。
核心结论
- MRI IDEAL IQ成像是一种无创方法,可用于评估和追踪宫颈癌同步放化疗中盆腔骨髓脂肪含量的变化。
- 应更加关注宫颈癌同步放化疗中低剂量骨髓照射体积的限制。
研究设计与样本
- 前瞻性收集54例宫颈癌同步放化疗患者的数据。
- 患者在放疗前、放疗中点、放疗结束及6个月时接受MRI IDEAL IQ扫描。
- 分析5-10 Gy、10-15 Gy、15-20 Gy、20-30 Gy、30-40 Gy、40-50 Gy及>50 Gy剂量区PDFF%的变化。
- 采用Spearman秩相关分析外周血细胞计数与治疗前后不同剂量梯度PDFF%差值之间的相关性。
主要发现
- ALC最低点出现在放疗中点,为放疗前的27.6%;WBC、ANC、PLT最低点出现在放疗结束时,分别为放疗前的52.4%、65.1%、69.3%。
- 放疗中点及放疗结束时PDFF%分别增加46.8%和58.5%。
- 放疗后6个月,5-30 Gy剂量区PDFF%较放疗结束下降4.71%,但较放疗前仍增加55.95%。
- PDFF%与5-10 Gy剂量区ANC最低点呈显著正相关(r=0.62,P=0.006)。
- PDFF%与5-10 Gy剂量区ALC最低点存在相关性(r=0.554,P=0.017)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To quantify the pelvic bone marrow (PBM) fat content changes receiving different radiation doses of concurrent chemoradiotherapy for cervical cancer and to determine association with peripheral blood cell counts. METHODS: The data of 54 patients were prospectively collected. Patients underwent MRI iterative decomposition of water and fat with echo asymmetrical and least squares estimation (IDEAL IQ) scanning at RT-Pre, RT mid-point, RT end, and six months. The changes in proton density fat fraction (PDFF%) at 5-10 Gy, 10-15 Gy, 15-20 Gy, 20-30 Gy, 30-40 Gy, 40-50 Gy, and > 50 Gy doses were analyzed. Spearman's rank correlations were performed between peripheral blood cell counts versus the differences in PDFF% at different dose gradients before and after treatment. RESULTS: The lymphocytes (ALC) nadirs appeared at the midpoint of radiotherapy, which was only 27.6% of RT-Pre; the white blood cells (WBC), neutrophils (ANC), and platelets (PLT) nadirs appeared at the end of radiotherapy which was 52.4%, 65.1%, and 69.3% of RT-Pre, respectively. At RT mid-point and RT-end, PDFF% increased by 46.8% and 58.5%, respectively. Six months after radiotherapy, PDFF% decreased by 4.71% under 5-30 Gy compared to RT-end, while it still increased by 55.95% compared to RT-Pre. There was a significant positive correlation between PDFF% and ANC nadirs at 5-10 Gy (r = 0.62, P = 0.006), and correlation was observed between PDFF% and ALC nadirs at 5-10 Gy (r = 0.554, P = 0.017). CONCLUSION: MRI IDEAL IQ imaging is a non-invasive approach to evaluate and track the changes of PBM fat content with concurrent chemoradiotherapy for cervical cancer. The limitation of low-dose bone marrow irradiation volume in cervical cancer concurrent chemoradiotherapy should be paid more attention to.
引用
- Wang C, Qin X, Gong G, et al. Correlation between changes of pelvic bone marrow fat content and hematological toxicity in concurrent chemoradiotherapy for cervical cancer. Radiat Oncol. 2022. PMID: 35392934. doi:10.1186/s13014-022-02029-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。